PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers discover a possible reason for drug resistance in breast tumors

2015-07-17
(Press-News.org) HER2 membrane proteins play a special role in certain types of breast cancer: amplified levels of HER2 drive unrestricted cell growth. HER2-tailored antibody-based therapeutics aim to prevent cancer cell growth. However, two-thirds of HER2 positive breast cancer patients develop resistance against HER2-targeting drugs. The reason for this is not yet understood. Researchers now found out, that HER2 dimers appeared to be absent from a small sub-population of resting SKBR3 breast cancer cells. This small subpopulation may have self-renewing properties that are resistant to HER2-antibody therapy and thus able to seed new tumor growth.

For their studies researchers from the INM - Leibniz-Institute for New Materials, Saarbrücken and from the German Cancer Research Center (DKFZ) in Heidelberg used a new electron microscopy method called Liquid STEM. It allows nanoscale studies of intact cells in their native liquid environment.

The scientists have studied the local variations of HER2 membrane protein and of its dimers. HER2 is a member of the human epidermal growth factor receptor (EGFR) family. These family members trigger cell growth signals, when two of the membrane proteins are bound into a protein complex (dimerization). This happens usually after the binding of a small protein, the epidermal growth factor, which circulates in the blood stream and serves as communicator to transmit signals that regulate cell growth. HER2 is special in the sense that it does not need the growth factor protein in order to form dimers. It is thus capable of triggering cell growth without external regulation. In certain types of breast cancer, amplified levels of HER2 and its dimerization are known to drive unrestricted cell growth. HER2-tailored antibody-based therapeutics entered clinical practice more than a decade ago. These drugs aim to prevent cell growth triggered by HER2 homo- and/or heterodimerization.

"We found out, that HER2 dimers appeared to be absent from a small sub-population of resting SKBR3 cells. Could such cells survive the therapy and then develop into a drug resistant cancer at a later stage? It thus seems to be of key significance to study this sub-population of cells with exceptional phenotype," says Niels de Jonge, head of the Innovative Electron Microscopy group.

HER2 dimerization processes were thus far mostly studied on the basis of cell population averages, for example, with biochemical methods using pooled cell material, and information about the localization of HER2 dimerization was lacking. Therefore, the researchers around de Jonge pioneered the electron microscopy method Liquid STEM to imaging these receptors on cancer cells. The cells were examined on a microchip placed in the electron microscope, and remained intact and in liquid. "Specimens cannot be studied in liquid with traditional electron microscopy", explains Professor de Jonge. "Cells are typically studied in dry state via thin sectioning of solid dried plastic embedded or frozen material. The role of HER proteins is a "hot" topic in cancer research but despite large research efforts using a wide range of techniques over the past decades this important information was not unveiled before. Our novel findings were obtained as a direct consequence of the high spatial resolution of Liquid STEM combined with its capability to study many intact cells in liquid," says de Jonge.

INFORMATION:

Original Publication: "Local variations of HER2 dimerization in breast cancer cells discovered by correlative fluorescence and liquid electron microscopy" was published in the new online journal Science Advances Sci. Adv. 1, e1500165 (2015) by D. B. Peckys, U. Korf, N. de Jonge.

The research was conducted by Prof. Dr. Niels de Jonge, Dr. Diana B. Peckys of the INM - Leibniz-Institute for New Materials in Saarbrücken together with the group of Dr. Ulrike Korf, Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ) in Heidelberg, Germany.

INM conducts research and development to create new materials - for today, tomorrow and beyond. Chemists, physicists, biologists, materials scientists and engineers team up to focus on these essential questions: Which material properties are new, how can they be investigated and how can they be tailored for industrial applications in the future? Four research thrusts determine the current developments at INM: New materials for energy application, new concepts for medical surfaces, new surface materials for tribological systems and nano safety and nano bio. Research at INM is performed in three fields: Nanocomposite Technology, Interface Materials, and Bio Interfaces. INM - Leibniz Institute for New Materials, situated in Saarbrücken, is an internationally leading centre for materials research. It is an institute of the Leibniz Association and has about 210 employees.



ELSE PRESS RELEASES FROM THIS DATE:

Lymphomas tied to metabolic disruption

2015-07-17
SAN ANTONIO (July 17, 2015) -- Researchers from the School of Medicine at The University of Texas Health Science Center at San Antonio have found evidence that directly links disrupted metabolism (energy production in cells) to a common and often fatal type of lymphoma. The finding was announced Thursday (July 16) in Nature Communications. "The link between metabolism and cancer has been proposed or inferred to exist for a long time, but what is more scarce is evidence for a direct connection -- genetic mutations in metabolic enzymes," said senior author Ricardo C.T. ...

Cholesterol metabolism in immune cells linked to HIV progression

2015-07-17
Lower levels of cholesterol in certain immune cells--a result of enhanced cholesterol metabolism within those cells--may help explain why some HIV-infected people are able to naturally control disease progression, according to research that will be presented in a poster at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) in Vancouver, Canada, and the pre-conference 2015 Towards an HIV Cure Symposium. The findings provide a basis for potential development of new approaches to control HIV infection by regulating cellular ...

Dairy products boost effectiveness of probiotics

2015-07-17
Washington, DC - July 17, 2015 - The success of probiotics for boosting human health may depend partly upon the food, beverage, or other material carrying the probiotics, according to research published on July 10th in Applied and Environmental Microbiology, a journal of the American Society for Microbiology. "Our findings indicate that the manner in which a probiotic is delivered--whether in food or supplement form--could influence how effective that probiotic is in delivering the desired health benefits," said corresponding author Maria Marco, PhD, an associate professor ...

Siting wind farms more quickly, cheaply

2015-07-17
When a power company wants to build a new wind farm, it generally hires a consultant to make wind speed measurements at the proposed site for eight to 12 months. Those measurements are correlated with historical data and used to assess the site's power-generation capacity. At the International Joint Conference on Artificial Intelligence later this month, MIT researchers will present a new statistical technique that yields better wind-speed predictions than existing techniques do -- even when it uses only three months' worth of data. That could save power companies time ...

New resource makes gene editing technology even more user-friendly

2015-07-17
Researchers at Harvard University and the University of California, San Diego, have developed a new user-friendly resource to accompany the powerful gene editing tool called CRISPR/Cas9, which has been widely adopted to make precise, targeted changes in DNA. This breakthrough has the potential to facilitate new discoveries in gene therapies and basic genetics research. The research was published in the July 13 issue of Nature Methods. The study describes an approach to simplify a laborious part of the gene editing process using the CRISPR/Cas9 system: choosing the best ...

Coaches can be a strong influence in preventing football injuries, say researchers

2015-07-17
ROSEMONT, IL - Teaching coaches about injury prevention and contact restrictions pays off, say researchers who tracked injury rates among youth football players during the 2014 season. "With an estimated three million youth aged 7 to 14 years old playing tackle football each year, preventing injuries is key. Our study showed that kids who received a comprehensive education from a coach had fewer injuries," said lead author Zachary Y. Kerr, PhD, MPH of the Datalys Center for Injury Research and Prevention. Kerr and his team had athletic trainers evaluate and track ...

U of M study explains why hemp and marijuana are different

2015-07-17
Genetic differences between hemp and marijuana determine whether Cannabis plants have the potential for psychoactivity, a new study by University of Minnesota scientists shows. "Given the diversity of cultivated forms of Cannabis, we wanted to identify the genes responsible for differences in drug content," says U of M plant biologist George Weiblen. While marijuana is rich in psychoactive tetrahydrocannabinol (THC), hemp produces mostly a non-euphoric cannabidiol (CBD), but the genetic basis for this difference was a matter of speculation until now. The study was published ...

Nanowires give 'solar fuel cell' efficiency a tenfold boost

2015-07-17
A solar cell that produces fuel rather than electricity. Researchers at Eindhoven University of Technology (TU/e) and FOM Foundation today present a very promising prototype of this in the journal Nature Communications. The material gallium phosphide enables their solar cell to produce the clean fuel hydrogen gas from liquid water. Processing the gallium phosphide in the form of very small nanowires is novel and helps to boost the yield by a factor of ten. And does so using ten thousand times less precious material. The electricity produced by a solar cell can be used ...

New catalyst for selective oxidation of methanol to dimethoxymethane under mild conditions

2015-07-17
This article describes the effect of the preparation method of binary oxide supports (TiO2-Al2O3) on catalytic performance of V2O5/TiO2-Al2O3 catalysts for methanol selective oxidation to dimethoxymethane (DMM). The optimized catalyst exhibits a methanol conversion of 48.9% and a high DMM selectivity of 89.9% at 393 K, superior to V2O5/TiO2 and V2O5/Al2O3 catalysts. Reported by Prof. Gong Jinlong of Tianjin University, the research article titled "Selective Oxidation of Methanol to Dimethoxymethane over V2O5/TiO2-Al2O3 Catalysts" was published on Science Bulletin June ...

A new satellite time transfer method based on two-way common-view comparison

2015-07-17
Time synchronization between ground and satellites is a key technology for satellite navigation system. With dual-channel satellite, a method called Two-Way Common-View (TWCV) satellite time transfer for Compass system is proposed in recent study. The title of the paper related to the study is "The method and experiment analysis of two-way common-view satellite time transfer for compass system", which is written by LIU Li from Beijing Satellite Navigation Center and published in SCIENCE CHINA Physics, Mechanics & Astronomy 2015, 58. The researcher combines both characteristics ...

LAST 30 PRESS RELEASES:

Protecting nature can safeguard cities from floods

NCSA receives honors in 2024 HPCwire Readers’ and Editors’ Choice Awards

Warning: Don’t miss Thanksgiving dinner, it’s more meaningful than you think

Expanding HPV vaccination to all adults aged 27-45 years unlikely to be cost-effective or efficient for HPV-related cancer prevention

Trauma care and mental health interventions training help family physicians prepare for times of war

Adapted nominal group technique effectively builds consensus on health care priorities for older adults

Single-visit first-trimester care with point-of-care ultrasound cuts emergency visits by 81% for non-miscarrying patients

Study reveals impact of trauma on health care professionals in Israel following 2023 terror attack

Primary care settings face barriers to screening for early detection of cognitive impairment

November/December Annals of Family Medicine Tip Sheet

Antibiotics initiated for suspected community-acquired pneumonia even when chest radiography results are negative

COVID-19 stay-at-home order increased reporting of food, housing, and other health-related social needs in Oregon

UW-led research links wildfire smoke exposure with increased dementia risk

Most U.S. adults surveyed trust store-bought turkey is free of contaminants, despite research finding fecal bacteria in ground turkey

New therapy from UI Health offers FDA-approved treatment option for brittle type 1 diabetes

Alzheimer's: A new strategy to prevent neurodegeneration

A clue to what lies beneath the bland surfaces of Uranus and Neptune

Researchers uncover what makes large numbers of “squishy” grains start flowing

Scientists uncover new mechanism in bacterial DNA enzyme opening pathways for antibiotic development

New study reveals the explosive secret of the squirting cucumber

Vanderbilt authors find evidence that the hunger hormone leptin can direct neural development in a leptin receptor–independent manner

To design better water filters, MIT engineers look to manta rays

Self-assembling proteins can be used for higher performance, more sustainable skincare products

Cannabis, maybe, for attention problems

Building a better path to recovery for OUD

How climate change threatens this iconic Florida bird

Study reveals new factor involved in controlling calorie expenditure

Managing forests with smart technologies

Clinical trial finds that adding the chemotherapy pill temozolomide to radiation therapy improves survival in adult patients with a slow-growing type of brain tumor

H.E.S.S. collaboration detects the most energetic cosmic-ray electrons and positrons ever observed

[Press-News.org] Researchers discover a possible reason for drug resistance in breast tumors